Dr. Jakub Tolar to Speak at Gene Therapy for Rare Diseases Symposium

March 3, 2017

Dr. Jakub Tolar, Executive Vice Dean, will be speaking at the New York Academy of Sciences for their one-day symposium, Gene Therapy for Rare Diseases. Many life-threatening rare diseases are due to a single gene mutation. Often, there are no effective treatment options, and affected children require constant, life-long, expensive care. Gene therapy shows promise as a clinical strategy for these disorders, and work is in progress to address the challenges of delivering safe, consistent, and durable gene therapy to targeted tissues. This symposium will explore recent advances, identify remaining issues to be addressed, and explore opportunities for the application of gene therapy to more common diseases.

Gene Therapy for Rare Diseases

Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

The New York Academy of Sciences

Share this post

You may also like:

Dr. Mustafa al'Absi is launching a study to seek to discover, in part, what effect marijuana use has on individuals trying to quit tobacco cigarette smoking.

To give patients the best care, to find solutions when there are no therapies, and to provide hope for the future, we have to have active and rigorous research.

Nathan Ratner, a third-year medical student at the University of Minnesota and third-place finisher in last year's Elsevier Hackathon in Finland, talks about the promise of mobile health technology.